These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28536352)

  • 21. Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon.
    Weidle UH; Georges G; Brinkmann U
    Cancer Genomics Proteomics; 2012; 9(3):119-33. PubMed ID: 22593247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
    Akinrinmade OA; Jordaan S; Hristodorov D; Mladenov R; Mungra N; Chetty S; Barth S
    Biomedicines; 2017 Jun; 5(3):. PubMed ID: 28653985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells.
    El-Mesery M; Trebing J; Schäfer V; Weisenberger D; Siegmund D; Wajant H
    Cell Death Dis; 2013 Nov; 4(11):e916. PubMed ID: 24232092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of programmed cell death in ErbB2/HER2-expressing cancer cells by targeted delivery of apoptosis-inducing factor.
    Mahmud H; Dälken B; Wels WS
    Mol Cancer Ther; 2009 Jun; 8(6):1526-35. PubMed ID: 19509241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics of granzymes: sequence comparison and structural studies on granzyme family by homology modeling.
    Sattar R; Ali SA; Abbasi A
    Biochem Biophys Res Commun; 2003 Sep; 308(4):726-35. PubMed ID: 12927779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of factor VIII-specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A.
    Brettschneider K; Schmidt A; Kahle J; Orlowski A; Stichel D; Schwabe D; Königs C
    J Thromb Haemost; 2018 Nov; 16(11):2223-2232. PubMed ID: 30152083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII-Fc Activates Natural Killer Cells
    Lagassé HAD; Hopkins LB; Jankowski W; Jacquemin MG; Sauna ZE; Golding B
    Front Immunol; 2021; 12():692157. PubMed ID: 34262568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
    Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.
    Hristodorov D; Nordlohne J; Mladenov R; Huhn M; Fischer R; Thepen T; Barth S
    Br J Haematol; 2014 Jan; 164(2):251-7. PubMed ID: 24164493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents.
    Liu Y; Cheung LH; Hittelman WN; Rosenblum MG
    Mol Cancer Ther; 2003 Dec; 2(12):1341-50. PubMed ID: 14707275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico target specific design of potential quinazoline-based anti-NSCLC agents.
    Mohammadnejadi E; Razzaghi-Asl N
    J Biomol Struct Dyn; 2023 Dec; 41(20):10725-10736. PubMed ID: 36826424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein.
    Hristodorov D; Amoury M; Mladenov R; Niesen J; Arens K; Berges N; Hein L; Di Fiore S; Pham AT; Huhn M; Helfrich W; Fischer R; Thepen T; Barth S
    Mol Cancer Ther; 2014 Sep; 13(9):2194-202. PubMed ID: 24980949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH.
    Liu X; Tan Q; Wen J; Wang X; Yang G; Li Y; Lu M; Ye W; Si A; Ma S; Ding T; Sun L; Liu F; Zhang M; Jiang T; Gao W
    J Transl Med; 2023 Aug; 21(1):572. PubMed ID: 37626430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and characterization of a recombinant immunotoxin for targeted therapy of breast cancer cells: In vitro and in silico analyses.
    Barazesh M; Mohammadi S; Jalili S; Kavousipour S; Faraji SN; Mokarram P; Pirhadi S
    Life Sci; 2021 Jan; 265():118866. PubMed ID: 33301810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
    Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
    Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.